Gt biopharma announces the promotion of dr. gregory berk to president of research & development and chief medical officer

Beverly hills, calif., aug. 23, 2021 /prnewswire/ -- gt biopharma, inc. (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager, trike ® protein biologic technology platform, today announced the promotion of gregory berk, m.d.
GTBP Ratings Summary
GTBP Quant Ranking